Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Arcturus Therapeutics Holdings Inc ARCT

Healthcare Biotechnology
Arcturus Therapeutics Holdings Inc. is a global messenger RNA medicines and vaccine company. The Company is focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. In addition to its messenger RNA (mRNA) platform, its lipid nanoparticle (LNP) delivery system, LUNAR, has the potential to enable multiple nucleic acid... see more

Recent & Breaking News (NDAQ:ARCT)

Alcobra Ltd. to Participate at Two Conferences in May

GlobeNewswire April 27, 2015

Alcobra Ltd. to Release First Quarter 2015 Financial Results and Host Corporate Update Conference Call & Webcast on May 6

GlobeNewswire April 16, 2015

Alcobra Ltd. to Present at Two CNS Focused Conferences in April

GlobeNewswire April 6, 2015

Alcobra's MDX Meets Primary Endpoint in Phase II Safety and Tolerability Clinical Trial in Adolescents With ADHD

GlobeNewswire March 10, 2015

Alcobra Ltd. to Present at 27th Annual ROTH Conference

GlobeNewswire March 3, 2015

Alcobra Announces Fourth Quarter and Fiscal Year 2014 Financial Results and Provides Corporate Update

GlobeNewswire February 12, 2015

Alcobra Ltd. to Release Fourth Quarter and Fiscal Year 2014 Financial Results and Host Corporate Update Conference Call & Webcast on February 12

GlobeNewswire February 2, 2015

Alcobra Ltd. to Present at BIO CEO & Investor Conference

GlobeNewswire January 29, 2015

UPCOMING DEADLINE: The Law Offices of Vincent Wong Notify Investors of Class Action Involving Alcobra Ltd. and a Lead Plaintiff Deadline of January 20, 2015

GlobeNewswire January 14, 2015

Alcobra Ltd. Announces Closing of Public Offering of Ordinary Shares and Full Exercise of Over-Allotment Option

GlobeNewswire January 14, 2015

Rosen Law Firm Reminds Alcobra Ltd. Investors of Important January 19, 2015 Deadline in Class Action - ADHD

GlobeNewswire January 12, 2015

INVESTOR ALERT: Glancy Binkow & Goldberg LLP Reminds Investors of the Lead Plaintiff Deadline in the Class Action Lawsuit Against Alcobra, Ltd.

Business Wire January 12, 2015

UPDATE - UPCOMING DEADLINE: LEVI & KORSINSKY, LLP Notifies Investors of Class Action Against Alcobra Ltd. and Its Board of Directors and a Lead Plaintiff Deadline of January 20, 2015 -- ADHD

Business Wire January 9, 2015

Alcobra Ltd. Prices Public Offering of Ordinary Shares

GlobeNewswire January 9, 2015

Alcobra Ltd. Announces Commencement of Public Offering of Ordinary Shares

GlobeNewswire January 8, 2015

Alcobra Ltd. Announces Commencement of Public Offering of Ordinary Shares

GlobeNewswire January 8, 2015

INVESTOR ALERT: Class Action Lawsuit Against Alcobra, Ltd. Announced by Law Offices of Howard G. Smith

Business Wire January 7, 2015

ADHD SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of Class Action Against Alcobra Ltd. and Its Board of Directors and a Lead Plaintiff Deadline of January 19, 2015 -- ADHD

PR Newswire January 2, 2015

SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Alcobra Ltd. To Contact Brower Piven Before The January 19, 2015 Lead Plaintiff Deadline In Class Action Lawsuit

Business Wire December 30, 2014

Alcobra Ltd. Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor Investigate Possible Breaches of Fiduciary Duty by Officers and Directors

Business Wire December 17, 2014